logo

Axsome Therapeutics Announces FDA Acceptance of NDA Resubmission for AXS-07 for the Acute Treatment of Migraine

  2 weeks ago   
post image
FDA sets PDUFA action goal date of January 31, 2025 FDA sets PDUFA action goal date of January ...
Ticker Sentiment Impact
AXSM
Neutral
11 %